Candace S Johnson Selected Research

Candace S Johnson Research Topics

Disease

69	Neoplasms (Cancer) 01/2023 - 01/2002
31	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 01/2002
19	Hypercalcemia (Milk Alkali Syndrome) 01/2016 - 01/2002
12	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2015 - 07/2002
7	Breast Neoplasms (Breast Cancer) 01/2021 - 02/2011
7	Urinary Bladder Neoplasms (Bladder Cancer) 01/2019 - 07/2010
7	Neoplasm Metastasis (Metastasis) 09/2017 - 05/2006
4	Vitamin D Deficiency 01/2019 - 02/2009
4	Leukemia 02/2014 - 05/2004
3	Inflammation (Inflammations) 01/2016 - 06/2010
3	Lung Neoplasms (Lung Cancer) 05/2008 - 05/2004
2	7 Hereditary Prostate Cancer 01/2019 - 01/2018
2	Adenocarcinoma 01/2014 - 03/2007
2	Colorectal Neoplasms (Colorectal Cancer) 08/2013 - 02/2009
2	Pancreatic Neoplasms (Pancreatic Cancer) 08/2010 - 01/2010
2	Lymphoma (Lymphomas) 07/2006 - 05/2004
1	Acute Pain 01/2023
1	Adenocarcinoma of Lung 03/2020
1	Residual Neoplasm 01/2019
1	Chronic Disease (Chronic Diseases) 01/2018
1	Granular Cell Tumor 10/2015
1	Carcinogenesis 09/2015
1	Mouth Neoplasms (Oral Cancer) 09/2015
1	Squamous Cell Carcinoma of Head and Neck 09/2015
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2014
1	Carcinoma (Carcinomatosis) 02/2014
1	Chromothripsis 02/2014

Drug/Important Bio-Agent (IBA)

43	Vitamin D FDA LinkGeneric 01/2021 - 01/2002
41	Calcitriol (Calcijex)FDA LinkGeneric 01/2016 - 01/2002
12	Dexamethasone (Maxidex)FDA LinkGeneric 01/2016 - 01/2002
11	AndrogensIBA 01/2014 - 01/2002
10	Cholecalciferol (Vitamin D3)FDA Link 03/2020 - 01/2006
9	hydroxide ionIBA 01/2019 - 01/2010
7	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 08/2002
7	GlucocorticoidsIBA 10/2011 - 01/2002
6	Calcitriol Receptors (Calcitriol Receptor)IBA 09/2017 - 09/2002
6	Vitamin D3 24-HydroxylaseIBA 01/2016 - 07/2010
6	Proteins (Proteins, Gene)FDA Link 01/2016 - 10/2003
5	Estrogen ReceptorsIBA 01/2021 - 02/2011
5	CalciumIBA 01/2018 - 07/2006
5	EnzymesIBA 01/2016 - 07/2006
5	25-hydroxyvitamin DIBA 01/2015 - 02/2011
5	Carboplatin (JM8)FDA LinkGeneric 07/2010 - 01/2002
4	1,25-dihydroxyvitamin DIBA 01/2019 - 07/2002
4	MicroRNAs (MicroRNA)IBA 04/2015 - 01/2014
4	Paclitaxel (Taxol)FDA LinkGeneric 07/2010 - 01/2002
4	Docetaxel (Taxotere)FDA Link 07/2010 - 05/2004
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 07/2014
3	LigandsIBA 01/2016 - 07/2006
3	Prostate-Specific Antigen (Semenogelase)IBA 01/2015 - 08/2002
3	DNA (Deoxyribonucleic Acid)IBA 02/2014 - 07/2010
3	Hormones (Hormone)IBA 01/2014 - 08/2004
3	Gemcitabine FDA Link 08/2010 - 07/2010
3	matrigelIBA 07/2010 - 09/2006
3	Taxoids (Taxanes)IBA 07/2006 - 01/2004
2	protein C activator peptideIBA 01/2018 - 01/2015
2	CarcinogensIBA 09/2015 - 05/2004
2	Cadherins (E-Cadherin)IBA 01/2014 - 02/2013
2	Antineoplastic Agents (Antineoplastics)IBA 01/2011 - 06/2010
2	SteroidsIBA 09/2010 - 07/2010
2	Cytidine DeaminaseIBA 08/2010 - 01/2007
2	MineralsIBA 07/2010 - 07/2006
2	Gefitinib (Iressa)FDA Link 12/2009 - 02/2007
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 08/2006 - 07/2004
2	VA 061 (VA061)IBA 07/2006 - 05/2004
2	allyl isothiocyanateIBA 10/2003 - 05/2003
2	2,3,4-tri-O-acetylarabinopyranosyl isothiocyanate (AITC)IBA 10/2003 - 05/2003
1	Opioid Analgesics (Opioids)IBA 01/2023
1	Tyrosine Kinase InhibitorsIBA 03/2020
1	MagnesiumIBA 01/2018
1	ORALIT (ORS)IBA 01/2018
1	AmberIBA 05/2016
1	N-nitroso-tris-chloroethylureaIBA 10/2015
1	pazopanib FDA Link 10/2015
1	4-Nitroquinoline-1-oxide (4 Nitroquinoline 1 oxide)IBA 09/2015
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2015
1	ErbB Receptors (EGF Receptor)IBA 09/2015
1	Calcifediol (Calcidiol)FDA Link 01/2015
1	NucleotidesIBA 02/2014
1	Ionotropic Glutamate ReceptorsIBA 02/2014
1	Interleukin-5 (Interleukin 5)IBA 01/2014
1	CytokinesIBA 01/2014
1	QW 1624F2-1IBA 01/2014
1	Differentiation AntigensIBA 01/2014
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 09/2013
1	Cell Adhesion MoleculesIBA 09/2013
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 09/2013
1	von Willebrand FactorIBA 09/2013
1	A-factor (Streptomyces)IBA 07/2013
1	Oxygen (Dioxygen)IBA 06/2013
1	Angiogenesis InhibitorsIBA 06/2013
1	LuciferasesIBA 04/2013
1	Casein Kinase II (Casein Kinase 2)IBA 04/2013

Therapy/Procedure

18	Therapeutics 01/2021 - 01/2002
3	Prostatectomy (Retropubic Prostatectomy) 02/2014 - 05/2009
3	Drug Therapy (Chemotherapy) 07/2010 - 02/2009
2	Castration 01/2014 - 01/2010
1	Cystectomy 01/2019
1	Segmental Mastectomy (Lumpectomy) 10/2016
1	Chemoprevention 09/2015